These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16048592)

  • 1. Sirolimus in pediatric solid organ transplantation.
    Dharnidharka VR
    Pediatr Transplant; 2005 Aug; 9(4):427-9. PubMed ID: 16048592
    [No Abstract]   [Full Text] [Related]  

  • 2. For organ transplant recipients, cancer threatens long-term survival.
    Ross K
    J Natl Cancer Inst; 2007 Mar; 99(6):421-2. PubMed ID: 17374827
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of mTOR-I on fertility and pregnancy: state of the art and review of the literature.
    Framarino-dei-Malatesta M; Derme M; Manzia TM; Iaria G; De Luca L; Fazzolari L; Napoli A; Berloco P; Patel T; Orlando G; Tisone G
    Expert Rev Clin Immunol; 2013 Aug; 9(8):781-9. PubMed ID: 23971756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus: a new immunosuppressant.
    Mukherjee T; Shah BV
    J Assoc Physicians India; 2005 Oct; 53():885-90. PubMed ID: 16459533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus does not reduce receptor-mediated endocytosis of albumin in proximal tubule cells.
    Mreich E; Coombes JD; Rangan GK
    Transplantation; 2007 Jan; 83(1):105-7. PubMed ID: 17220808
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment with sirolimus ameliorates tacrolimus-induced autoimmune cytopenias after solid organ transplant.
    Teachey DT; Jubelirer T; Baluarte HJ; Wade A; Manno CS
    Pediatr Blood Cancer; 2009 Dec; 53(6):1114-6. PubMed ID: 19621445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression in pediatric solid organ transplantation.
    Agarwal A; Pescovitz MD
    Semin Pediatr Surg; 2006 Aug; 15(3):142-52. PubMed ID: 16818135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of Sirolimus in five pediatric patients undergoing solid organ transplantation].
    Roque E J; Ríos M G; Vignolo A P; Pinochet V C; Schultz M; Humeres A R; Delucchi A; Rius A M; Hepp K J
    Rev Med Chil; 2008 May; 136(5):631-6. PubMed ID: 18769812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonimmunosuppressive effects of mammalian target of rapamycin inhibitors.
    Cruzado JM
    Transplant Rev (Orlando); 2008 Jan; 22(1):73-81. PubMed ID: 18631860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials.
    Demopoulos L; Polinsky M; Steele G; Mines D; Blum M; Caulfield M; Adamkovic A; Liu Q; Harler MB; Hahn C; Singh A
    Transplant Proc; 2008 Jun; 40(5):1407-10. PubMed ID: 18589118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complications of immunosuppressive therapy in organ transplantation].
    Jørgensen KA; Dieperink H; Kirkegaard P
    Ugeskr Laeger; 2003 Dec; 165(49):4727-9. PubMed ID: 14708378
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pro- and antitumor effects of the main immunosuppressive drugs used in the clinical practice of transplantation].
    Marchini F
    G Ital Nefrol; 2007; 24(2):171. PubMed ID: 17458835
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacogenetics in solid organ transplantation: current status and future directions.
    de Jonge H; Kuypers DR
    Transplant Rev (Orlando); 2008 Jan; 22(1):6-20. PubMed ID: 18631854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression in pediatric solid organ transplantation: opportunities, risks, and management.
    Tredger JM; Brown NW; Dhawan A
    Pediatr Transplant; 2006 Dec; 10(8):879-92. PubMed ID: 17096754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus in pediatric liver transplantation: a single-center experience.
    Gibelli NE; Tannuri U; Pinho-Apezzato ML; Tannuri AC; Maksoud-Filho JG; Andrade WC; Velhote MC; Santos MM; Ayoub AA; Marques da Silva M
    Transplant Proc; 2009 Apr; 41(3):901-3. PubMed ID: 19376384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamune: a novel macrolide immunosuppressant for transplantation.
    Latta D
    Hum Exp Toxicol; 2000 Apr; 19(4):229. PubMed ID: 10918513
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients.
    Andrés V; Castro C; Campistol JM
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii14-7. PubMed ID: 16815851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of sirolimus metabolites in pediatric solid organ transplant recipients.
    Filler G; Bendrick-Peart J; Strom T; Zhang YL; Johnson G; Christians U
    Pediatr Transplant; 2009 Feb; 13(1):44-53. PubMed ID: 18482220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Getting rid of steroids in pediatric solid-organ transplantation?
    Reding R; Webber SA; Fine R
    Pediatr Transplant; 2004 Dec; 8(6):526-30. PubMed ID: 15598317
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological action of rapamycin in renal transplantation.
    Weichhart T; Werzowa J; Hörl WH; Säemann MD
    Am J Kidney Dis; 2008 Mar; 51(3):531; author reply 531-2. PubMed ID: 18295073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.